regulatory t cells
Human CD3+ T Cells (Pan T Cells), Cryopreserved |
|||
| M1299-30 | Biovision | each | Ask for price |
Human CD3+ T Cells (Pan T Cells), Cryopreserved |
|||
| M1299-40 | Biovision | each | Ask for price |
Untransduced T Cells |
|||
| 78170-1 | BPS Bioscience | 1 vial | 1250 EUR |
|
Description: The untransduced T cells are produced by mock lentiviral transduction of human primary CD4+CD8+ T cells. These cells are subjected to comparable manipulations as CAR-T cells: activation, spinoculation (without lentivirus), and expansion. These T cells are meant to be negative controls in experiments using lentivirus-transduced primary CAR-T cells. |
|||
Untransduced T Cells |
|||
| 78170-2 | BPS Bioscience | 5 vials | 3325 EUR |
|
Description: The untransduced T cells are produced by mock lentiviral transduction of human primary CD4+CD8+ T cells. These cells are subjected to comparable manipulations as CAR-T cells: activation, spinoculation (without lentivirus), and expansion. These T cells are meant to be negative controls in experiments using lentivirus-transduced primary CAR-T cells. |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC042884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC042884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCA2884-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), APC conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCAP2884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCAP2884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCH2884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCH2884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCP2884-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC942884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC942884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC802884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC802884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC812884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC812884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCR2884-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCB2884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNCB2884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC882884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC882884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC612884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC612884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC432884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC432884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC402884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC402884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC552884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC552884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC702884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC702884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC052884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC052884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC472884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC472884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC682884-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNC682884-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNUB2884-100 | Biotium | 100uL | 316.8 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Concentration: 0.2mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNUB2884-50 | Biotium | 50uL | 486 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), 1mg/mL |
|||
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R) Antibody |
|||
| BNUB2884-500 | Biotium | 500uL | 615.6 EUR |
|
Description: Primary antibody against CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), Concentration: 0.2mg/mL |
|||
anti-CD45 RA B-cells, T-cells, NK-cells |
|||
| 516-A-01mg | Virogen | 0,1 mg | 321 EUR |
|
Description: anti-CD45 RA B-cells, T-cells, NK-cells |
|||
anti-CD45 RA B-cells, T-cells, NK-cells |
|||
| 516-A-1000ug | Virogen | 1000 ug | 1539 EUR |
|
Description: anti-CD45 RA B-cells, T-cells, NK-cells |
|||
T-Pro Stacking Buffer |
|||
| JB03-C002 | T-Pro Biotechnology | 500ml/BT | 182.4 EUR |
T-Pro MycoClean spray |
|||
| JT90-R002 | T-Pro Biotechnology | 500ml/BT | 172.8 EUR |
anti-CD4 T helper cells |
|||
| 502-A-01mg | Virogen | 0,1 mg | 321 EUR |
|
Description: anti-CD4 T helper cells |
|||
anti-CD4 T helper cells |
|||
| 502-A-1000ug | Virogen | 1000 ug | 1539 EUR |
|
Description: anti-CD4 T helper cells |
|||
anti-CD5 All T-cells |
|||
| 503-A-01mg | Virogen | 0,1 mg | 321 EUR |
|
Description: anti-CD5 All T-cells |
|||
anti-CD5 All T-cells |
|||
| 503-A-1000ug | Virogen | 1000 ug | 1539 EUR |
|
Description: anti-CD5 All T-cells |
|||
anti-CD7 All T-cells |
|||
| 504-A-01mg | Virogen | 0,1 mg | 321 EUR |
|
Description: anti-CD7 All T-cells |
|||
anti-CD7 All T-cells |
|||
| 504-A-1000ug | Virogen | 1000 ug | 1539 EUR |
|
Description: anti-CD7 All T-cells |
|||
Anti-CD19 CAR-T Cells |
|||
| 78171-1 | BPS Bioscience | 1 vial | 1595 EUR |
|
Description: The anti-CD19 CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ; SIN Vector, BPS Bioscience, #78601). These ready-to use CAR-T cells express an anti-CD19 CAR consisting the ScFv of CD19 (clone FMC63) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains. These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays. |
|||
Anti-CD19 CAR-T Cells |
|||
| 78171-2 | BPS Bioscience | 5 vials | 4250 EUR |
|
Description: The anti-CD19 CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ; SIN Vector). These ready-to use CAR-T cells express an anti-CD19 CAR consisting the ScFv of CD19 (clone FMC63) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains.These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays. |
|||
Anti-BCMA CAR-T Cells |
|||
| 78660-1 | BPS Bioscience | 1 vial | 1595 EUR |
|
Description: The anti-BCMA CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-BCMA CAR Lentivirus (BPS Bioscience #78655). These ready-to-use CAR-T cells express an anti-BCMA CAR consisting of the ScFv of BCMA (clone C11D5.3) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1). These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays. |
|||
Anti-BCMA CAR-T Cells |
|||
| 78660-2 | BPS Bioscience | 5 vials | 4250 EUR |
|
Description: The anti-BCMA CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-BCMA CAR Lentivirus (BPS Bioscience #78655). These ready-to-use CAR-T cells express an anti-BCMA CAR consisting of the ScFv of BCMA (clone C11D5.3) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3ζ signaling domains (Figure 1). These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays. |
|||
T-Pro EZ Gel Solution 8% |
|||
| JB02-B008M | T-Pro Biotechnology | 500ml/BT | 266.4 EUR |
T-Pro EZ Gel Solution 8% |
|||
| JB02-B008S | T-Pro Biotechnology | 100ml/BT | 162 EUR |
T-Pro EZ Gel Solution 10% |
|||
| JB02-B010M | T-Pro Biotechnology | 500ml/BT | 266.4 EUR |
T-Pro EZ Gel Solution 10% |
|||
| JB02-B010S | T-Pro Biotechnology | 100ml/BT | 162 EUR |
T-Pro EZ Gel Solution 12% |
|||
| JB02-B012M | T-Pro Biotechnology | 500ml/BT | 266.4 EUR |
T-Pro EZ Gel Solution 12% |
|||
| JB02-B012S | T-Pro Biotechnology | 100ml/BT | 162 EUR |
T-Pro EZ Gel Solution 15% |
|||
| JB02-B015M | T-Pro Biotechnology | 500ml/BT | 266.4 EUR |
T-Pro EZ Gel Solution 15% |
|||
| JB02-B015S | T-Pro Biotechnology | 100ml/BT | 162 EUR |
T-Pro Separating or Resolving Buffer |
|||
| JB03-C001 | T-Pro Biotechnology | 500ml/BT | 182.4 EUR |
T-Pro BCA Protein Assay kit |
|||
| JB04-D001 | T-Pro Biotechnology | 500assay/KIT | 244.8 EUR |
T-Pro Transfer Blotting buffer (10X) |
|||
| JB08-H001 | T-Pro Biotechnology | 500ml/BT | 162 EUR |
T-Pro Western Blot Stripping Reagent |
|||
| JB11-K002 | T-Pro Biotechnology | 500ml/BT | 213.6 EUR |
T-Pro Aqua EZ Clean (M) |
|||
| JT90-R001M | T-Pro Biotechnology | 500ml/BT | 398.4 EUR |
T-Pro Aqua EZ Clean (S) |
|||
| JT90-R001S | T-Pro Biotechnology | 100ml/BT | 181.2 EUR |
T-Pro EZ stain Gel solution |
|||
| JT90-R005M | T-Pro Biotechnology | 500ml/BT | 224.4 EUR |
T-Pro EZ stain Gel solution |
|||
| JT90-R005S | T-Pro Biotechnology | 100ml/BT | 151.2 EUR |
T-Pro P-Fect Transfection Reagent |
|||
| JT97-N005M | T-Pro Biotechnology | 1.0ml/vial | 266.4 EUR |
T-Pro Plasmid Mini Kit (100) |
|||
| RB94-YPD100 | T-Pro Biotechnology | 100preps/Kit | 193.2 EUR |
T-Pro Plasmid Mini Kit (250) |
|||
| RB94-YPD250 | T-Pro Biotechnology | 250preps/Kit | 266.4 EUR |
T-Pro Plasmid Midi Kit (20) |
|||
| RB94-YPI020 | T-Pro Biotechnology | 20preps/Kit | 255.6 EUR |
T-Pro Plasmid Maxi Kit (10) |
|||
| RB94-YPM010 | T-Pro Biotechnology | 10preps/Kit | 266.4 EUR |
anti-CD8 T cytotoxic/supressor cells |
|||
| 505-A-01mg | Virogen | 0,1 mg | 321 EUR |
|
Description: anti-CD8 T cytotoxic/supressor cells |
|||
anti-CD8 T cytotoxic/supressor cells |
|||
| 505-A-1000ug | Virogen | 1000 ug | 1539 EUR |
|
Description: anti-CD8 T cytotoxic/supressor cells |
|||
CD4+ T cells, Negatively Selected (Human) |
|||
| 79752 | BPS Bioscience | 10 million cells | 395 EUR |
|
Description: Cryopreserved vial (10 x 10^6 cells) of CD4+ T cells that were negatively selected from freshly isolated primary human peripheral blood mononuclear cells (PBMCs). The PBMCs came from a healthy donor, and were isolated from whole blood or leukapheresis samples using a Ficoll gradient. Magnetic antibodies to monocytes, granulocytes, CD8+ T cells, gamma/delta T cells and other immune subsets present in PBMCs were then used to purify untouched CD4+ T cells via immunomagnetic separation. Before and after CD4+ T cell isolation, the cells were stained to evaluate purity and viability by flow cytometry. Cells were cryopreserved in CryoStor CS10 cryopreservation medium (Stemcell, #07930) at a controlled rate._x000D_Source Normal human PBMC from Leukapheresis Sample |
|||
CD8+ T cells, Negatively Selected (Human) |
|||
| 79753 | BPS Bioscience | 10 million cells | 495 EUR |
|
Description: Cryopreserved vial (10 x 10^6 cells) of CD8+ T cells that were negatively selected from freshly isolated primary human peripheral blood mononuclear cells (PBMCs). The PBMCs came from a healthy donor, and were isolated from whole blood or leukapheresis samples using a Ficoll gradient. Magnetic antibodies to monocytes, granulocytes, CD4+ T cells, gamma/delta T cells and other immune subsets present in PBMCs were then used to purify untouched CD8+ T cells via immunomagnetic separation. Before and after CD8+ T cell isolation, the cells were stained to evaluate purity and viability by flow cytometry. Cells were cryopreserved in CryoStor CS10 cryopreservation medium (Stemcell, #07930) at a controlled rate._x000D_Source Normal human PBMC from Leukapheresis Sample |
|||
T-Pro BCA Protein Assay Reagent A |
|||
| JB04-D001A | T-Pro Biotechnology | 500ml/BT | 204 EUR |
T-Pro BCA Protein Assay Reagent B |
|||
| JB04-D001B | T-Pro Biotechnology | 12ml/BT | 140.4 EUR |
T-Pro Bradford Protein Assay kit(1X) |
|||
| JB04-D002 | T-Pro Biotechnology | 500ml/BT | 193.2 EUR |
T-Pro Fast Blocking Buffer (in PBS) |
|||
| JK92-W001 | T-Pro Biotechnology | 500ml/BT | 224.4 EUR |